» Articles » PMID: 26672726

Consensus on the Prevention, Screening, Early Diagnosis and Treatment of Colorectal Tumors in China: Chinese Society of Gastroenterology, October 14-15, 2011, Shanghai, China

Overview
Date 2015 Dec 18
PMID 26672726
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Colorectal cancer (CRC) is steadily increasing in China. Colorectal adenoma (CRA) is the most important precancerous disease of CRC. Screening for colorectal tumors can aid early diagnosis. Advances in endoscopic mucosal resection and endoscopic submucosal dissection can aid the early treatment of colorectal tumors. Furthermore, because of high risk of recurrence after removal of adenomas under endoscopy, factors contributing to recurrence, the follow-up mode and the interval established, and the feasibility of application and the time of various chemical preventions should be concerned. However, a relevant consensus on the screening, early diagnosis and treatment, and prevention of colorectal tumors in China is lacking.

Summary: The consensus recommendations include epidemiology, pathology, screening, early diagnosis, endoscopic treatment, monitoring and follow-up, and chemoprevention of colorectal tumors in China.

Key Message: This is the first consensus on the prevention, screening, early diagnosis and treatment of CRA and CRC in China based on evidence in the literature and on local data.

Practical Implications: Through reviewing the literature, regional data and passing the consensus by an anonymous vote, gastroenterology experts from all over China launch the consensus recommendations in Shanghai. The incidence and mortality of CRC in China has increased, and the incidence or detection rate of CRA has increased rapidly. Screening for colorectal tumors should be performed at age 50-74 years. Preliminary screening should be undertaken to find persons at high risk, followed by colonoscopy. A screening cycle of 3 years is recommended for persistent interventions. Opportunistic screening is a mode suitable for the current healthcare system and national situation. Colonoscopy combined with pathological examination is the standard method for the diagnosis of colorectal tumors. CRA removal under endoscopy can prevent CRC to some extent, but CRA has an obvious recurrence trend. The follow-up interval after the removal or surgery of colorectal tumors should be different with lesions. Primary prevention of CRA includes improved diet with more fiber, supplements containing calcium and vitamin D, supplements containing folic acid for those with low hemoglobin levels, and cessation of tobacco smoking. Non-steroidal anti-inflammatory drugs and selective cyclooxygenase-2 inhibitors have been recognized to prevent recurrence after adenoma removal.

Citing Articles

Application of fecal immunochemical test in colorectal cancer screening: A community-based, cross-sectional study in average-risk individuals in Hainan.

Zeng F, Zhang D, Chen S, Chen R, Chen C, Huang S World J Gastrointest Oncol. 2024; 16(8):3445-3456.

PMID: 39171167 PMC: 11334025. DOI: 10.4251/wjgo.v16.i8.3445.


Chinese national clinical practice guidelines on prevention, diagnosis and treatment of early colorectal cancer.

Li J, Yao H, Lu Y, Zhang S, Zhang Z Chin Med J (Engl). 2024; 137(17):2017-2039.

PMID: 39104005 PMC: 11374253. DOI: 10.1097/CM9.0000000000003253.


Changing Colorectal Cancer Trends in Asians: Epidemiology and Risk Factors.

Pardamean C, Sudigyo D, Budiarto A, Mahesworo B, Hidayat A, Baurley J Oncol Rev. 2023; 17:10576.

PMID: 37284188 PMC: 10241074. DOI: 10.3389/or.2023.10576.


Combined SUVmax and localized colonic wall thickening parameters to identify high-risk lesions from incidental focal colorectal F-FDG uptake foci.

Xu W, Li H, Guo Z, Zhang L, Zhang R, Zhang L Front Oncol. 2022; 12:972096.

PMID: 36033516 PMC: 9416927. DOI: 10.3389/fonc.2022.972096.


Developing and validating polygenic risk scores for colorectal cancer risk prediction in East Asians.

Ping J, Yang Y, Wen W, Kweon S, Matsuda K, Jia W Int J Cancer. 2022; 151(10):1726-1736.

PMID: 35765848 PMC: 9509464. DOI: 10.1002/ijc.34194.


References
1.
Tanaka S, Oka S, Chayama K . Colorectal endoscopic submucosal dissection: present status and future perspective, including its differentiation from endoscopic mucosal resection. J Gastroenterol. 2008; 43(9):641-51. DOI: 10.1007/s00535-008-2223-4. View

2.
Winawer S, Zauber A, Fletcher R, Stillman J, OBrien M, Levin B . Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology. 2006; 130(6):1872-85. DOI: 10.1053/j.gastro.2006.03.012. View

3.
Eaden J, Abrams K, Mayberry J . The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001; 48(4):526-35. PMC: 1728259. DOI: 10.1136/gut.48.4.526. View

4.
Froehlich F, Wietlisbach V, Gonvers J, Burnand B, Vader J . Impact of colonic cleansing on quality and diagnostic yield of colonoscopy: the European Panel of Appropriateness of Gastrointestinal Endoscopy European multicenter study. Gastrointest Endosc. 2005; 61(3):378-84. DOI: 10.1016/s0016-5107(04)02776-2. View

5.
Kiesslich R, Burg J, Vieth M, Gnaendiger J, Enders M, Delaney P . Confocal laser endoscopy for diagnosing intraepithelial neoplasias and colorectal cancer in vivo. Gastroenterology. 2004; 127(3):706-13. DOI: 10.1053/j.gastro.2004.06.050. View